The Head of Rosselkhoznadzor stressed that there are domestic substitutes for almost all foreign-made immunobiological drugs.
“We have enough vaccines to substitute the foreign ones,” said Sergey Dankvert.
He also told the senators how foreign drugs hit the Russian market. “When livestock and poultry farming started developing in Russia the foreigners had it simple: if you take our eggs, you should also take our vaccines, as we have technical assistance, consulting support,” explained the Head of the Service, and added, that there is a number of foreign companies, that actively engaged in market penetration.
Sergey Dankvert said that the share of imported immunobiological drugs reaches 17,5 billion, while Russian share is 13,5 billion. “We can make that grow,” said the Head of the Service.
V&L previously reported that according to the National Veterinary Association, Russian animal health companies are willing to replace up to 100 % of veterinary pharmaceuticals and up to 40% of immunobiological drugs in the market. But to do that they need state support. In particular, they ask to subsidize the purchase of raw materials and request “license holiday” to speed up the launch of new production plants.